Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study.


Journal

BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488

Informations de publication

Date de publication:
10 06 2020
Historique:
entrez: 12 6 2020
pubmed: 12 6 2020
medline: 20 6 2020
Statut: epublish

Résumé

To examine the protective effects of appropriate personal protective equipment for frontline healthcare professionals who provided care for patients with coronavirus disease 2019 (covid-19). Cross sectional study. Four hospitals in Wuhan, China. 420 healthcare professionals (116 doctors and 304 nurses) who were deployed to Wuhan by two affiliated hospitals of Sun Yat-sen University and Nanfang Hospital of Southern Medical University for 6-8 weeks from 24 January to 7 April 2020. These study participants were provided with appropriate personal protective equipment to deliver healthcare to patients admitted to hospital with covid-19 and were involved in aerosol generating procedures. 77 healthcare professionals with no exposure history to covid-19 and 80 patients who had recovered from covid-19 were recruited to verify the accuracy of antibody testing. Covid-19 related symptoms (fever, cough, and dyspnoea) and evidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, defined as a positive test for virus specific nucleic acids in nasopharyngeal swabs, or a positive test for IgM or IgG antibodies in the serum samples. The average age of study participants was 35.8 years and 68.1% (286/420) were women. These study participants worked 4-6 hour shifts for an average of 5.4 days a week; they worked an average of 16.2 hours each week in intensive care units. All 420 study participants had direct contact with patients with covid-19 and performed at least one aerosol generating procedure. During the deployment period in Wuhan, none of the study participants reported covid-19 related symptoms. When the participants returned home, they all tested negative for SARS-CoV-2 specific nucleic acids and IgM or IgG antibodies (95% confidence interval 0.0 to 0.7%). Before a safe and effective vaccine becomes available, healthcare professionals remain susceptible to covid-19. Despite being at high risk of exposure, study participants were appropriately protected and did not contract infection or develop protective immunity against SARS-CoV-2. Healthcare systems must give priority to the procurement and distribution of personal protective equipment, and provide adequate training to healthcare professionals in its use.

Identifiants

pubmed: 32522737
doi: 10.1136/bmj.m2195
pmc: PMC7284314
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

m2195

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: grant funding from the First Affiliated Hospital of Sun Yat-sen University; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Références

Influenza Other Respir Viruses. 2011 May;5(3):170-9
pubmed: 21477136
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
JAMA. 2020 Mar 26;:
pubmed: 32215589
J Med Virol. 2020 Apr 22;:
pubmed: 32320064
Front Med. 2020 Apr;14(2):229-231
pubmed: 32212058
Clin Infect Dis. 2020 Mar 17;:
pubmed: 32179890
J Med Virol. 2020 Jul;92(7):903-908
pubmed: 32219885
J Med Virol. 2020 Apr 9;:
pubmed: 32270882
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481
pubmed: 32298247
Lancet Public Health. 2020 May;5(5):e251-e252
pubmed: 32199083
JAMA. 2020 Feb 7;:
pubmed: 32031570
Clin Infect Dis. 2020 Mar 28;:
pubmed: 32221519
Lancet. 2003 May 3;361(9368):1519-20
pubmed: 12737864
Epidemics. 2017 Sep;20:1-20
pubmed: 28487207
J Hosp Infect. 2020 May;105(1):100-101
pubmed: 32147406

Auteurs

Min Liu (M)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Shou-Zhen Cheng (SZ)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Ke-Wei Xu (KW)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Yang Yang (Y)

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Qing-Tang Zhu (QT)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Hui Zhang (H)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Da-Ya Yang (DY)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Shu-Yuan Cheng (SY)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Han Xiao (H)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China xiaohp@mail.sysu.edu.cn.

Ji-Wen Wang (JW)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

He-Rui Yao (HR)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Yu-Tian Cong (YT)

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Yu-Qi Zhou (YQ)

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Sui Peng (S)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Ming Kuang (M)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.

Fan-Fan Hou (FF)

Nan Fang Hospital, Southern Medical University, Guangzhou, China.

K K Cheng (KK)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Hai-Peng Xiao (HP)

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China xiaohp@mail.sysu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH